Literature DB >> 6979349

Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material.

S Haskill, S Becker, W Fowler, L Walton.   

Abstract

Malignant effusions and tumour tissue obtained at surgery provided material for a study of the prognostic value of the various inflammatory cells in the prognosis of human ovarian cancer. Ascitic fluids predominantly contained inflammatory cells; tumour cells, both singly and in clusters, were a minor component. Tumour cells were usually in excess in dispersed solid material. Some patients had significant proportions of lymphocytes and macrophages in their solid tumour, and these patients invariably responded to therapy. Sedimentation-velocity separation at unit gravity provided tow populations of inflammatory cells. One consisted of mononuclear cells similar in size to those in the patients blood: the other consisted of one or more large macrophage populations, distinct in morphology and enzymatic markers from both blood monocytes and each other. T lymphocytes were enriched in ascites fractions (78%) and in the tumour-derived mononuclear fraction (71%) compared to patient blood (60%). The T-cell subset characterized by ANAE reactivity was markedly depleted in the tumour-infiltrating fraction (17%) compared to patient blood (62%) or patient blood (51%). Esterase-positive monocyte-like cells were more frequent in the tumour-infiltrating fraction (17%) than ascites (7%) or blood (12%). B lymphocytes were infrequent in solid tumours and difficult to assess in ascites. Histiocyte-like macrophages were present in the higher-velocity tumour-cell containing fractions of both solid and ascitic material. The variation in infiltrating cells between patients and between tumour and ascites of the same individual was marked.

Entities:  

Mesh:

Year:  1982        PMID: 6979349      PMCID: PMC2011001          DOI: 10.1038/bjc.1982.114

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen.

Authors:  L Moretta; M C Mingari; A Moretta; M D Cooper
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

2.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

3.  Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. I. Composition of the inflammatory infiltrates.

Authors:  P Häyry; T H Tötterman
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

4.  The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.

Authors:  J S Haskill; M Key; L A Radov; E Parthenais; J H Korn; J W Fett; Y Yamamura; F DeLustro; J Vesley; G Gant
Journal:  J Reticuloendothel Soc       Date:  1979-10

Review 5.  The stromal reaction of tumors: an expression of immune surveillance.

Authors:  H L Ioachim
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

6.  In situ Fc receptor-bearing cells in two murine tumors. I. Isolation and identification.

Authors:  J H Korn; J S Haskill; H T Holden; L A Radov; F L Ritter
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

7.  Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors.

Authors:  A Mantovani; G Peri; N Polentarutti; G Bolis; C Mangioni; F Spreafico
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

8.  Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.

Authors:  S Becker; S Haskill
Journal:  Int J Cancer       Date:  1980-04-15       Impact factor: 7.396

Review 9.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

10.  Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.

Authors:  J A Werkmeister; E Pihl; A P Nind; G R Flannery; R C Nairn
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

View more
  25 in total

1.  Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene HOXA9.

Authors:  Song Yi Ko; Honami Naora
Journal:  Cancer Cell Microenviron       Date:  2014-11-13

Review 2.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

3.  Immunity and immune suppression in human ovarian cancer.

Authors:  Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Journal:  Immunotherapy       Date:  2011-04       Impact factor: 4.196

4.  Morphological and functional characteristics of mouse mammary carcinoma cells separated on Nycodenz columns.

Authors:  T C Ford; T Lai; M O Symes
Journal:  Br J Exp Pathol       Date:  1987-06

Review 5.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

6.  Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

Authors:  Mathias Krockenberger; Yvonne Dombrowski; Claudia Weidler; Monika Ossadnik; Arnd Hönig; Sebastian Häusler; Heike Voigt; Jürgen C Becker; Lin Leng; Alexander Steinle; Michael Weller; Richard Bucala; Johannes Dietl; Jörg Wischhusen
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

7.  In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.

Authors:  G Gattringer; R Greil; T Radaszkiewicz; H Huber
Journal:  Blut       Date:  1986-07

8.  The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

Authors:  R P Negus; G W Stamp; M G Relf; F Burke; S T Malik; S Bernasconi; P Allavena; S Sozzani; A Mantovani; F R Balkwill
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 9.  Therapeutic strategies for targeting the ovarian tumor stroma.

Authors:  Song Yi Ko; Honami Naora
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

10.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.